Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The rising prevalence of chronic myeloid leukemia in France.
Delord M, Foulon S, Cayuela JM, Rousselot P, Bonastre J. Delord M, et al. Among authors: bonastre j. Leuk Res. 2018 Jun;69:94-99. doi: 10.1016/j.leukres.2018.04.008. Epub 2018 Apr 17. Leuk Res. 2018. PMID: 29734071
[Editorial].
Perrier L; French Costing Group. Perrier L, et al. Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S63-S64. doi: 10.1016/j.respe.2018.02.004. Epub 2018 Feb 24. Rev Epidemiol Sante Publique. 2018. PMID: 29487012 French. No abstract available.
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial.
Le Cesne A, Blay JY, Cupissol D, Italiano A, Delcambre C, Penel N, Isambert N, Chevreau C, Bompas E, Bertucci F, Chaigneau L, Piperno-Neumann S, Salas S, Rios M, Guillemet C, Bay JO, Ray-Coquard I, Haddag L, Bonastre J, Kapso R, Fraslin A, Bouvet N, Mir O, Foulon S. Le Cesne A, et al. Among authors: bonastre j. Ann Oncol. 2021 Aug;32(8):1034-1044. doi: 10.1016/j.annonc.2021.04.014. Epub 2021 Apr 29. Ann Oncol. 2021. PMID: 33932507 Free article. Clinical Trial.
Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study.
Rousseau A, Michiels S, Simon-Tillaux N, Lolivier A, Bonastre J, Planchard D, Barlesi F, Remon J, Lavaud P, Aldea M, Frelaut M, Le Pechoux C, Botticella A, Levy A, Gazzah A, Foulon S, Besse B. Rousseau A, et al. Among authors: bonastre j. Lancet Reg Health Eur. 2024 Jun 29;43:100970. doi: 10.1016/j.lanepe.2024.100970. eCollection 2024 Aug. Lancet Reg Health Eur. 2024. PMID: 39040528 Free PMC article.
Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
Lafuma A, Cotté FE, Le Tourneau C, Emery C, Gaudin AF, Torreton E, Gourmelen J, Bonastre J. Lafuma A, et al. Among authors: bonastre j. J Med Econ. 2019 Jul;22(7):698-705. doi: 10.1080/13696998.2019.1594837. Epub 2019 Apr 2. J Med Econ. 2019. PMID: 30895832 Free article.
117 results